XTX Topco Ltd raised its position in shares of Itron, Inc. (NASDAQ:ITRI - Free Report) by 120.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,399 shares of the scientific and technical instruments company's stock after acquiring an additional 5,682 shares during the quarter. XTX Topco Ltd's holdings in Itron were worth $1,111,000 as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in ITRI. Sculptor Capital LP acquired a new stake in shares of Itron in the second quarter valued at approximately $5,255,000. Assenagon Asset Management S.A. increased its holdings in shares of Itron by 7.8% in the second quarter. Assenagon Asset Management S.A. now owns 268,379 shares of the scientific and technical instruments company's stock valued at $26,559,000 after purchasing an additional 19,387 shares during the last quarter. Skandinaviska Enskilda Banken AB publ increased its holdings in shares of Itron by 97.8% in the second quarter. Skandinaviska Enskilda Banken AB publ now owns 10,207 shares of the scientific and technical instruments company's stock valued at $1,012,000 after purchasing an additional 5,047 shares during the last quarter. Driehaus Capital Management LLC acquired a new stake in shares of Itron in the second quarter valued at approximately $18,758,000. Finally, Intech Investment Management LLC increased its holdings in shares of Itron by 105.9% in the third quarter. Intech Investment Management LLC now owns 19,444 shares of the scientific and technical instruments company's stock valued at $2,077,000 after purchasing an additional 10,001 shares during the last quarter. Institutional investors and hedge funds own 96.19% of the company's stock.
Itron Stock Down 2.4 %
NASDAQ:ITRI traded down $2.71 during midday trading on Tuesday, reaching $112.43. The company had a trading volume of 538,793 shares, compared to its average volume of 515,473. The firm has a market capitalization of $5.07 billion, a price-to-earnings ratio of 23.04, a PEG ratio of 0.87 and a beta of 1.46. The stock's fifty day simple moving average is $112.41 and its 200-day simple moving average is $105.75. Itron, Inc. has a 12-month low of $67.21 and a 12-month high of $124.90. The company has a current ratio of 3.36, a quick ratio of 2.83 and a debt-to-equity ratio of 0.91.
Itron (NASDAQ:ITRI - Get Free Report) last released its earnings results on Thursday, October 31st. The scientific and technical instruments company reported $1.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.13 by $0.71. The firm had revenue of $615.46 million during the quarter, compared to analyst estimates of $596.41 million. Itron had a return on equity of 19.03% and a net margin of 9.37%. Itron's revenue was up 9.8% compared to the same quarter last year. During the same period last year, the business posted $0.98 earnings per share. On average, sell-side analysts anticipate that Itron, Inc. will post 5.33 earnings per share for the current fiscal year.
Insider Buying and Selling at Itron
In other Itron news, CEO Thomas Deitrich sold 37,500 shares of the firm's stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $104.83, for a total value of $3,931,125.00. Following the sale, the chief executive officer now directly owns 205,276 shares in the company, valued at $21,519,083.08. This trade represents a 15.45 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.45% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
Several equities research analysts recently commented on ITRI shares. Robert W. Baird increased their price target on Itron from $123.00 to $132.00 and gave the company an "outperform" rating in a report on Friday, November 1st. Guggenheim increased their price objective on Itron from $128.00 to $135.00 and gave the stock a "buy" rating in a research report on Wednesday, November 6th. Oppenheimer increased their price objective on Itron from $120.00 to $124.00 and gave the stock an "outperform" rating in a research report on Friday, November 1st. Janney Montgomery Scott assumed coverage on Itron in a research report on Friday, September 27th. They issued a "buy" rating and a $131.00 price objective for the company. Finally, Roth Mkm increased their price objective on Itron from $125.00 to $130.00 and gave the stock a "buy" rating in a research report on Friday, November 1st. Four research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $123.92.
Get Our Latest Research Report on Itron
Itron Company Profile
(
Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Read More
Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.